Ellen-Margrethe Hauge
Overview
Explore the profile of Ellen-Margrethe Hauge including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
110
Citations
879
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Matt M, Drozdov D, Bendstrup E, Glerup M, Hauge E, Masmas T, et al.
Lancet Rheumatol
. 2024 Dec;
PMID: 39718183
Background: Systemic juvenile idiopathic arthritis-related lung disease (sJIA-LD) is a severe complication in patients with treatment-refractory systemic juvenile idiopathic arthritis (sJIA). The objective of this study was to evaluate the...
2.
Glintborg B, Hansson M, Hammer H, Klareskog L, Saevarsdottir S, Westerlind H, et al.
Scand J Public Health
. 2024 Dec;
52(8):1019-1025.
PMID: 39651649
Aims: Personalised medicine in chronic complex diseases such as rheumatoid arthritis (RA) is within reach but requires international multi-stakeholder collaboration. We exemplify how national implementations of the General Data Protection...
3.
Larsen M, Voss A, Nielsen C, Hauge E, Faurschou M, Troldborg A
Ugeskr Laeger
. 2024 Nov;
186(47).
PMID: 39575908
Chimeric antigen receptor T-cell (CAR-T) therapy is emerging as a novel treatment for systemic autoimmune rheumatic diseases. To date, CAR-T therapy in rheumatology has been reported only in case studies...
4.
Therkildsen J, Klose-Jensen R, Hanel M, Langdahl B, Thomsen J, Manske S, et al.
Joint Bone Spine
. 2024 Nov;
92(1):105812.
PMID: 39547428
Objective: To compare the number of new erosions in two metacarpophalangeal (MCP) joints over one year assessed by high-resolution peripheral quantitative computed tomography (HR-pQCT) and conventional radiography (CR). Furthermore, to...
5.
Hansen M, Hansen I, Keller K, Therkildsen P, Hauge E, Nielsen B
Rheumatology (Oxford)
. 2024 Oct;
PMID: 39400596
Objectives: To evaluate sensitivity and scores of vascular ultrasound (US) before and after initiating glucocorticoid (GC) treatment in patients with new-onset giant cell arteritis (GCA). Methods: Treatment-naïve patients with GCA...
6.
Knudsen L, Lomborg K, Hauge E, de Thurah A
BMC Health Serv Res
. 2024 Sep;
24(1):1104.
PMID: 39304859
Background: The integration of telehealth interventions into clinical practice is frequently delayed, hindering the full adoption. Previously, we developed a digital patient education (PE) programme for self-management in rheumatoid arthritis...
7.
Nielsen A, Hauge E, Hansen I, Nielsen B, Kjaer S, Blegvad J, et al.
Rheumatology (Oxford)
. 2024 Aug;
PMID: 39180419
Objective: The objective was to investigate the incidence of late-onset giant cell arteritis (GCA) within the first year in patients diagnosed with polymyalgia rheumatica (PMR). Methods: In this prospective study,...
8.
Cheneymann A, Therkildsen J, Rasmussen L, Thygesen J, Isaksen C, Hauge E, et al.
Calcif Tissue Int
. 2024 Aug;
115(4):421-431.
PMID: 39152302
Osteoporosis is under-diagnosed while detectable by measuring bone mineral density (BMD) using quantitative computer tomography (QCT). Opportunistic screening for low BMD has previously been suggested using lumbar QCT. However, thoracic...
9.
Nielsen A, van der Geest K, Hansen I, Nielsen B, Kjaer S, Blegvad-Nissen J, et al.
Rheumatology (Oxford)
. 2024 Jul;
PMID: 39058504
Purpose: In routine care, clinicians may employ 2-[18F]fluoro-2-deoxy-D-glucose (FDG) positron emission tomography (PET) computed tomography (CT) to validate their initial clinical diagnosis of polymyalgia rheumatica (PMR). Nevertheless, the diagnostic utility...
10.
Uhrenholt L, Sorensen M, Lauridsen K, Duch K, Dreyer L, Christensen R, et al.
Rheumatol Int
. 2024 Jul;
44(10):1897-1908.
PMID: 39043980
To evaluate tumour necrosis factor inhibitor (TNFi) drug-levels and presence of anti-drug antibodies (ADAb) in patients with inflammatory arthritis who taper TNFi compared to TNFi continuation. Patients with rheumatoid arthritis,...